Paria BC et al. |
Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. |
1999 |
Biol. Reprod. |
pmid:10208977
|
Leweke FM et al. |
Elevated endogenous cannabinoids in schizophrenia. |
1999 |
Neuroreport |
pmid:10501554
|
Akinshola BE et al. |
Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. |
1999 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10543424
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. |
1999 |
Curr. Med. Chem. |
pmid:10469888
|
Kuwae T et al. |
Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. |
1999 |
FEBS Lett. |
pmid:10508930
|
McAllister SD et al. |
Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10525080
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Melck D et al. |
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. |
1999 |
FEBS Lett. |
pmid:10606728
|
Childers SR and Breivogel CS |
Cannabis and endogenous cannabinoid systems. |
1998 Jun-Jul |
Drug Alcohol Depend |
pmid:9716939
|
Brăiloiu C et al. |
[Endothelium-derived hyperpolarizing factor]. |
1998 Jul-Dec |
Rev Med Chir Soc Med Nat Iasi |
pmid:10756843
|
McGregor IS et al. |
A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. |
1998 |
Brain Res. |
pmid:9748483
|
Schneider U et al. |
Cannabinoid/anandamide system and schizophrenia: is there evidence for association? |
1998 |
Pharmacopsychiatry |
pmid:9754842
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Pestonjamasp VK and Burstein SH |
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. |
1998 |
Biochim. Biophys. Acta |
pmid:9795237
|
White R and Hiley CR |
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. |
1998 |
Br. J. Pharmacol. |
pmid:9806337
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Murillo-RodrÃguez E et al. |
Anandamide modulates sleep and memory in rats. |
1998 |
Brain Res. |
pmid:9813364
|
Jaggar SI et al. |
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder. |
1998 |
Neurosci. Lett. |
pmid:9774165
|
Fulton D and Quilley J |
Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732371
|
Welch SP et al. |
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732392
|
Fields HL and Meng ID |
Watching the pot boil. |
1998 |
Nat. Med. |
pmid:9734389
|
Pate DW et al. |
Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. |
1998 |
Life Sci. |
pmid:9851310
|
Molina-Holgado F et al. |
The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. |
1998 |
FEBS Lett. |
pmid:9738948
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Prevot V et al. |
Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. |
1998 |
Brain Res. |
pmid:9593913
|
Di Marzo V |
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. |
1998 |
Biochim. Biophys. Acta |
pmid:9630590
|
Stefano GB et al. |
Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. |
1998 |
Brain Res. |
pmid:9630717
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Varga K et al. |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. |
1998 |
FASEB J. |
pmid:9707176
|
Mallet PE and Beninger RJ |
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. |
1998 |
Life Sci. |
pmid:9651110
|
De Petrocellis L et al. |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9653194
|
Berdyshev E et al. |
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. |
1998 |
Life Sci. |
pmid:9718090
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Bisogno T et al. |
Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703957
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Axelrod J and Felder CC |
Cannabinoid receptors and their endogenous agonist, anandamide. |
1998 |
Neurochem. Res. |
pmid:9566594
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Di Marzo V et al. |
Interactions between synthetic vanilloids and the endogenous cannabinoid system. |
1998 |
FEBS Lett. |
pmid:9801167
|
Van der Kloot W et al. |
Calcitonin gene-related peptide acts presynaptically to increase quantal size and output at frog neuromuscular junctions. |
1998 |
J. Physiol. (Lond.) |
pmid:9508830
|
Stein EA et al. |
Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. |
1998 |
Neuropsychopharmacology |
pmid:9803424
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Giuffrida A and Piomelli D |
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. |
1998 |
FEBS Lett. |
pmid:9498819
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Kimura T et al. |
Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. |
1998 |
Biol. Pharm. Bull. |
pmid:9556149
|